Uwe Koedel Selected Research

Uwe Koedel Research Topics

Disease

30	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 02/2024 - 01/2002
29	Bacterial Meningitis 04/2024 - 01/2002
23	Meningitis 01/2023 - 01/2002
17	Infections 04/2024 - 10/2003
11	Inflammation (Inflammations) 02/2024 - 01/2002
10	Leukocytosis (Pleocytosis) 04/2024 - 11/2002
7	Pneumococcal Infections 10/2022 - 01/2003
5	Brain Injuries (Brain Injury) 07/2020 - 01/2007
4	Meningococcal Meningitis 04/2024 - 12/2014
4	Hearing Loss (Hearing Impairment) 10/2013 - 04/2003
3	Disease Progression 02/2024 - 11/2011
3	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 11/2011
3	Hemorrhage 04/2019 - 12/2014
3	Brain Edema (Cerebral Edema) 01/2007 - 01/2003
2	Central Nervous System Infections (Central Nervous System Infection) 01/2023 - 10/2008
2	Viral Meningitis 07/2005 - 04/2003
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2005 - 01/2003
2	Necrosis 06/2004 - 08/2003
2	Guillain-Barre Syndrome 04/2003 - 11/2002
1	Meningococcal Infections 04/2024
1	Thrombosis (Thrombus) 04/2024
1	Communicable Diseases (Infectious Diseases) 04/2024
1	Cerebral Hemorrhage 10/2022
1	Seizures (Absence Seizure) 01/2021
1	Fever (Fevers) 01/2021
1	Neoplasms (Cancer) 10/2019
1	Lymphoma (Lymphomas) 10/2019
1	Clinical Deterioration 04/2019
1	Gliosis 01/2019
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2018
1	Lyme Disease (Disease, Lyme) 01/2017

Drug/Important Bio-Agent (IBA)

17	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 12/2002
14	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2002
12	ChemokinesIBA 11/2023 - 11/2002
11	CytokinesIBA 11/2023 - 12/2002
6	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 04/2024 - 10/2003
6	Interleukin-6 (Interleukin 6)IBA 04/2024 - 01/2003
5	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 12/2002
5	Messenger RNA (mRNA)IBA 10/2022 - 03/2002
5	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2012 - 04/2007
4	Pattern Recognition ReceptorsIBA 08/2012 - 01/2003
4	Interleukin-1beta (Interleukin 1 beta)IBA 09/2006 - 01/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2004 - 01/2002
3	Plasminogen Activators (Plasminogen Activator)IBA 10/2022 - 11/2002
3	Matrix Metalloproteinases (MMPs)IBA 07/2020 - 08/2003
3	Plasminogen Activator Inhibitor 1IBA 04/2014 - 11/2002
3	AntibodiesIBA 01/2014 - 08/2003
3	Complement System Proteins (Complement)IBA 10/2011 - 06/2004
2	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2023
2	Plasminogen Activator Inhibitor 2IBA 10/2022 - 03/2005
2	batimastat (BB 94)IBA 07/2020 - 12/2014
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 12/2014
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2018 - 08/2003
2	paquinimodIBA 11/2017 - 07/2015
2	Adenosine Triphosphate (ATP)IBA 01/2017 - 11/2011
2	InflammasomesIBA 01/2017 - 11/2011
2	AntioxidantsIBA 10/2013 - 10/2003
2	Acetylcysteine (Siran)FDA LinkGeneric 10/2013 - 12/2006
2	Toll-Like Receptor 2IBA 12/2009 - 01/2003
2	src-Family KinasesIBA 10/2008 - 01/2007
2	Complement Receptors (Complement Receptor)IBA 10/2008 - 01/2003
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2007 - 09/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2007 - 07/2005
2	NitrogenIBA 12/2006 - 09/2006
2	Urokinase Plasminogen Activator ReceptorsIBA 03/2005 - 11/2002
2	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 06/2004 - 01/2003
2	Chemokine CX3CL1IBA 04/2003 - 02/2003
2	Peptide Hydrolases (Proteases)FDA Link 12/2002 - 12/2002
2	Oxidants (Oxidizing Agents)IBA 12/2002 - 12/2002
1	Interleukin-8 (Interleukin 8)IBA 04/2024
1	FibrinIBA 04/2024
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 04/2024
1	Interleukin-10 (Interleukin 10)IBA 10/2022
1	SteroidsIBA 01/2022
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2021
1	Bacterial DNAIBA 01/2021
1	Conjugate VaccinesIBA 01/2021
1	Matrix Metalloproteinase InhibitorsIBA 07/2020
1	Doxycycline (Periostat)FDA LinkGeneric 07/2020
1	Tetracycline (Achromycin)FDA LinkGeneric 07/2020
1	Neuroprotective AgentsIBA 07/2020
1	B-Cell Activating FactorIBA 10/2019
1	LigandsIBA 10/2019
1	Acyclovir (Aciclovir)FDA LinkGeneric 04/2019
1	ProteomeIBA 01/2019
1	Sialic AcidsIBA 01/2019
1	OligopeptidesIBA 01/2019
1	Virulence Factors (Pathogenicity Factors)IBA 01/2019
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019
1	Cell Adhesion MoleculesIBA 01/2019
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 01/2018
1	Daptomycin FDA Link 11/2017
1	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2017
1	HMGB1 Protein (HMG1)IBA 11/2017
1	InterleukinsIBA 01/2017

Therapy/Procedure

25	Therapeutics 04/2024 - 01/2002
2	Critical Care (Surgical Intensive Care) 12/2006 - 01/2005
1	Contraindications 01/2021
1	Decompressive Craniectomy 04/2019
1	Complementary Therapies (Alternative Medicine) 01/2017